Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Green tea extract and Peganum harmala ointment for genital warts in women
IRCT20241225064163N2Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of green tea extract and Peganum harmala extract in anogenital warts, sponsored by Mashhad University of Medical Sciences. Started May 2025; status: completed.
02
Drugs
green tea extractPeganum harmala extract
03
Conditions
anogenital warts
Beyond the preview
Go deeper on IRCT20241225064163N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241225064163N2.